http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014041119-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d51a3bbd3fa1ddc931c4f18ecd02cb9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
filingDate 2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53636c79086d577cdba20d06e6813328
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_263fb80df8b221e7a33f4f545101ff3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6574f32e2fa96cab41f4b1578e590ae0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cc7cec91702c3d1bda6897d5d5b5b63
publicationDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014041119-A1
titleOfInvention Oncolytic viruses expressing immuno-nucleases
abstract The present invention relates to an oncolytic virus comprising an expressible genetic construct encoding a fusion polypeptide, wherein said fusion polypeptide comprises a polypeptide binding to a tumor related cell and a polypeptide having a cytotoxic nuclease activity, and to said oncolytic virus for use as a medicament and for the treatment of cancer. The present invention further relates to a method of killing tumor related cells comprising contacting said tumor related cells with the oncolytic virus of the present invention, incubating said tumor related cells under conditions allowing expression of said expressible genetic construct, and thereby killing said tumor related cells. Further, the present invention relates to the use of the oncolytic virus of the invention for the treatment of cancer and for killing cancer cells, as well as to kits and devices comprising said oncolytic virus.
priorityDate 2012-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129195613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500

Total number of triples: 39.